WO1995015746A1
(en)
*
|
1993-12-10 |
1995-06-15 |
The School Of Pharmacy |
Liposome delivery systems
|
US5931809A
(en)
*
|
1995-07-14 |
1999-08-03 |
Depotech Corporation |
Epidural administration of therapeutic compounds with sustained rate of release
|
US6544523B1
(en)
|
1996-11-13 |
2003-04-08 |
Chiron Corporation |
Mutant forms of Fas ligand and uses thereof
|
AU5465498A
(en)
|
1996-12-13 |
1998-07-03 |
Michael Kunitani |
Analysis and separation of platelet-derived growth factor proteins
|
US6511477B2
(en)
*
|
1997-03-13 |
2003-01-28 |
Biocardia, Inc. |
Method of drug delivery to interstitial regions of the myocardium
|
US6443949B2
(en)
*
|
1997-03-13 |
2002-09-03 |
Biocardia, Inc. |
Method of drug delivery to interstitial regions of the myocardium
|
EP1014946B1
(en)
|
1997-09-18 |
2010-04-07 |
Pacira Pharmaceuticals, Inc. |
Sustained-release liposomal anesthetic compositions
|
BR9813930A
(pt)
|
1997-11-06 |
2006-12-19 |
Chiron Spa |
antìgeno neisserial
|
JP4575592B2
(ja)
|
1997-11-14 |
2010-11-04 |
パシラ ファーマシューティカルズ インコーポレーテッド |
多小胞リポソームの製造
|
AU1979599A
(en)
|
1998-01-14 |
1999-08-02 |
Chiron S.P.A. |
(neisseria meningitidis) antigens
|
EP2261347A3
(en)
|
1998-05-01 |
2012-01-11 |
Novartis Vaccines and Diagnostics, Inc. |
Neisseria meningitidis antigens and compositions
|
US6740643B2
(en)
*
|
1999-01-21 |
2004-05-25 |
Mirus Corporation |
Compositions and methods for drug delivery using amphiphile binding molecules
|
NZ513829A
(en)
*
|
1999-03-02 |
2001-09-28 |
Liposome Co Inc |
Encapsulation of bioactive complexes in liposomes
|
CN100392082C
(zh)
|
1999-04-30 |
2008-06-04 |
启龙股份公司 |
保守的奈瑟球菌抗原
|
GB9911683D0
(en)
|
1999-05-19 |
1999-07-21 |
Chiron Spa |
Antigenic peptides
|
GB9916529D0
(en)
|
1999-07-14 |
1999-09-15 |
Chiron Spa |
Antigenic peptides
|
AUPQ259399A0
(en)
|
1999-09-01 |
1999-09-23 |
Lustre Investments Pte Ltd |
Therapeutic agents
|
ES2541830T3
(es)
|
1999-10-29 |
2015-07-27 |
Novartis Vaccines And Diagnositics S.R.L. |
Péptidos antigénicos de Neisseria
|
ATE446365T1
(de)
|
1999-11-18 |
2009-11-15 |
Novartis Vaccines & Diagnostic |
Menschliches fgf-21 gen und genexpressionsprodukte
|
US20070219363A1
(en)
*
|
1999-11-29 |
2007-09-20 |
Budker Vladimir G |
Chelating Compound for Drug Delivery
|
IL150374A0
(en)
|
1999-12-23 |
2002-12-01 |
Neurochem Inc |
Compounds and methods for modulating cerebral amyloid angiopathy
|
PT1248647E
(pt)
|
2000-01-17 |
2010-11-18 |
Novartis Vaccines & Diagnostics Srl |
Vacina de vesícula da membrana externa (omv) compreendendo proteínas de membrana externa de n. meningitidis do serogrupo b
|
AU2001249125A1
(en)
|
2000-03-08 |
2001-09-17 |
Chiron Corporation |
Human fgf-23 gene and gene expression products
|
EP1950297A2
(en)
|
2000-05-31 |
2008-07-30 |
Novartis Vaccines and Diagnostics, Inc. |
Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers
|
US7700359B2
(en)
|
2000-06-02 |
2010-04-20 |
Novartis Vaccines And Diagnostics, Inc. |
Gene products differentially expressed in cancerous cells
|
WO2003057926A1
(en)
|
2002-01-08 |
2003-07-17 |
Chiron Corporation |
Gene products differentially expressed in cancerous breast cells and their methods of use
|
JP5363695B2
(ja)
|
2000-06-15 |
2013-12-11 |
ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド |
結腸癌に関するポリヌクレオチド
|
EP2277895B1
(en)
|
2000-10-27 |
2013-08-14 |
Novartis Vaccines and Diagnostics S.r.l. |
Nucleic acids and proteins from streptococcus groups A & B
|
US20020160991A1
(en)
*
|
2000-12-04 |
2002-10-31 |
Liming Shao |
Orally-bioavailable formulations of fentanyl and congeners thereof
|
EP2336368A1
(en)
|
2000-12-07 |
2011-06-22 |
Novartis Vaccines and Diagnostics, Inc. |
Endogenous retroviruses up-regulated in prostate cancer
|
GB0107661D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Staphylococcus aureus
|
GB0107658D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Streptococcus pneumoniae
|
WO2002081642A2
(en)
|
2001-04-06 |
2002-10-17 |
Georgetown University |
Gene brcc-3 and diagnostic and therapeutic uses thereof
|
WO2002081639A2
(en)
|
2001-04-06 |
2002-10-17 |
Georgetown University |
Gene brcc2 and diagnostic and therapeutic uses thereof
|
AU2002305151A1
(en)
|
2001-04-06 |
2002-10-21 |
Georgetown University |
Gene scc-112 and diagnostic and therapeutic uses thereof
|
BR0102252B1
(pt)
*
|
2001-04-10 |
2013-10-22 |
|
Sistema de liberação controlada para antagonista do receptor AT1 da angiotensina II, composição farmacêutica e seu uso
|
EP1404713A4
(en)
|
2001-05-24 |
2004-09-22 |
Human Dna Technology Inc |
NEW KERATINOCYTE GROWTH FACTOR 2 ANALOG IN HAIR FOLLICULES
|
FR2827516B1
(fr)
*
|
2001-07-19 |
2003-09-19 |
Servier Lab |
Composition pharmaceutique pour l'administration par voie nasale d'estradiol et de norethisterone
|
BRPI0105509B8
(pt)
*
|
2001-11-05 |
2021-05-25 |
Univ Minas Gerais |
formulações do peptídeo angiotensina-(1-7) usando as ciclodextrinas, lipossomas e o polímero plga
|
CN100398551C
(zh)
|
2001-11-09 |
2008-07-02 |
乔治敦大学 |
新的血管内皮细胞生长抑制剂同种型
|
US20050106162A1
(en)
|
2001-12-12 |
2005-05-19 |
Guido Grandi |
Immunisation against chlamydia trachomatis
|
EP2093233A1
(en)
|
2002-03-21 |
2009-08-26 |
Sagres Discovery, Inc. |
Novel compositions and methods in cancer
|
US7244565B2
(en)
|
2002-04-10 |
2007-07-17 |
Georgetown University |
Gene shinc-3 and diagnostic and therapeutic uses thereof
|
ATE545651T1
(de)
|
2002-06-13 |
2012-03-15 |
Novartis Vaccines & Diagnostic |
Vektoren zur expression von hml-2-polypeptiden
|
EP1543841A4
(en)
*
|
2002-08-15 |
2011-03-16 |
Yunqing Liu |
SOLID PHARMACEUTICAL NANO FORMULATION AND MANUFACTURING METHOD THEREFOR
|
UA80447C2
(en)
|
2002-10-08 |
2007-09-25 |
|
Methods for treating pain by administering nerve growth factor antagonist and opioid analgesic
|
ATE466875T1
(de)
|
2002-11-15 |
2010-05-15 |
Novartis Vaccines & Diagnostic |
Unerwartete oberflächenproteine in neisseria meningitidis
|
US9498530B2
(en)
|
2002-12-24 |
2016-11-22 |
Rinat Neuroscience Corp. |
Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same
|
US7569364B2
(en)
|
2002-12-24 |
2009-08-04 |
Pfizer Inc. |
Anti-NGF antibodies and methods using same
|
CA2921578C
(en)
|
2002-12-24 |
2017-02-14 |
Rinat Neuroscience Corp. |
Anti-ngf antibodies and methods using same
|
US20070149449A1
(en)
|
2003-02-14 |
2007-06-28 |
Morris David W |
Therapeutic targets in cancer
|
US7767387B2
(en)
|
2003-06-13 |
2010-08-03 |
Sagres Discovery, Inc. |
Therapeutic targets in cancer
|
US20040170982A1
(en)
|
2003-02-14 |
2004-09-02 |
Morris David W. |
Novel therapeutic targets in cancer
|
BRPI0407375A
(pt)
|
2003-02-19 |
2006-02-07 |
Rinat Neuroscience Corp |
Métodos para tratar dor por meio da administração de um antagonista do fator de crescimento neural e u nsaid e composições contendo os mesmos
|
GB0308198D0
(en)
|
2003-04-09 |
2003-05-14 |
Chiron Srl |
ADP-ribosylating bacterial toxin
|
ES2426915T3
(es)
|
2003-09-10 |
2013-10-25 |
Brentwood Equities Ltd. |
Diastereoisómeros de 4-ariloxi-3-hidroxipiperidinas
|
AU2004308482A1
(en)
|
2003-12-23 |
2005-07-14 |
Rinat Neuroscience Corp. |
Agonist anti-trkC antibodies and methods using same
|
ES2407465T3
(es)
|
2004-03-29 |
2013-06-12 |
Galpharma Co., Ltd. |
Nueva proteína galectina 9 modificada y uso de la misma
|
HUE037549T2
(hu)
|
2004-04-07 |
2018-09-28 |
Rinat Neuroscience Corp |
Eljárások csontrákfájdalom kezelésére idegi növekedési faktor antagonista antitest beadásával
|
KR100896697B1
(ko)
|
2004-04-09 |
2009-05-14 |
(주)아모레퍼시픽 |
고압유화기술에 의한 대황추출물의 경피흡수 촉진방법 및이를 응용한 미백용 피부 외용제 조성물
|
PT2495252T
(pt)
|
2004-07-09 |
2018-06-22 |
Henry M Jackson Found Advancement Military Medicine Inc |
Formas solúveis de glicoproteína g de vírus hendra e de vírus nipah
|
US20060024677A1
(en)
|
2004-07-20 |
2006-02-02 |
Morris David W |
Novel therapeutic targets in cancer
|
AP2007003890A0
(en)
|
2004-07-30 |
2007-02-28 |
Rinat Neuroscience Corp |
Antibodies directed against amy-loid-beta peptide and methods using same
|
US7666442B2
(en)
*
|
2004-08-31 |
2010-02-23 |
Tracie Martyn International, Llc |
Topical compositions comprising benfotiamine and pyridoxamine
|
US7939490B2
(en)
|
2004-12-13 |
2011-05-10 |
University Of Maryland, Baltimore |
TWEAK as a therapeutic target for treating central nervous system diseases associated with cerebral edema and cell death
|
CN101203529A
(zh)
|
2005-02-18 |
2008-06-18 |
诺华疫苗和诊断公司 |
来自脑膜炎/脓毒症相关性大肠杆菌的蛋白质和核酸
|
JP2008535853A
(ja)
|
2005-04-07 |
2008-09-04 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス インコーポレイテッド |
癌関連遺伝子
|
CA2604885A1
(en)
|
2005-04-07 |
2006-10-19 |
Guoying Yu |
Cacna1e in cancer diagnosis, detection and treatment
|
TW200726485A
(en)
*
|
2005-07-01 |
2007-07-16 |
Alza Corp |
Liposomal delivery vehicle for hydrophobic drugs
|
JP4997239B2
(ja)
|
2005-07-22 |
2012-08-08 |
ワイズ・エー・シー株式会社 |
抗cd26抗体およびその使用方法
|
US8591457B2
(en)
|
2005-08-10 |
2013-11-26 |
Alza Corporation |
Method for making a needle-free jet injection drug delivery device
|
MY153249A
(en)
|
2005-11-14 |
2015-01-29 |
Rinat Neuroscience Corp |
Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
|
US7658913B2
(en)
|
2005-11-28 |
2010-02-09 |
Verrow Pharmaceuticals, Inc. |
Compositions useful for reducing nephrotoxicity and methods of use thereof
|
NZ568288A
(en)
*
|
2005-11-28 |
2012-02-24 |
Verrow Pharmaceuticals Inc |
Compositions comprising a a cyclodextrin and a nephrotoxic anticancer drug
|
KR100793824B1
(ko)
|
2006-03-06 |
2008-01-11 |
(주)아모레퍼시픽 |
하이드록시프로필-베타사이클로 덱스트린을 이용하여가용화된 유용성 생리활성성분을 담지하는 고분자-리포좀나노복합체
|
TW200808352A
(en)
*
|
2006-02-02 |
2008-02-16 |
Rinat Neuroscience Corp |
Methods for treating unwanted weight loss or eating disorders by administering a TRKB agonist
|
EP1988920A1
(en)
*
|
2006-02-02 |
2008-11-12 |
Rinat Neuroscience Corp. |
Methods for treating obesity by administering a trkb antagonist
|
SG172684A1
(en)
|
2006-06-07 |
2011-07-28 |
Bioalliance Cv |
Antibodies recognizing a carbohydrate containing epitope on cd-43 and cea expressed on cancer cells and methods using same
|
DK2054431T3
(da)
|
2006-06-09 |
2012-01-02 |
Novartis Ag |
Konformere af bakterielle adhæsiner
|
EP2064230A2
(en)
|
2006-08-16 |
2009-06-03 |
Novartis AG |
Immunogens from uropathogenic escherichia coli
|
AP2009005028A0
(en)
|
2007-04-10 |
2009-12-31 |
Univ Tulane |
Soluble and membrane-anchored forms of lassa virussubunit proteins
|
GB0714963D0
(en)
|
2007-08-01 |
2007-09-12 |
Novartis Ag |
Compositions comprising antigens
|
JP5737944B2
(ja)
|
2007-12-17 |
2015-06-17 |
ファイザー・リミテッドPfizer Limited |
間質性膀胱炎の治療
|
SG186669A1
(en)
|
2007-12-18 |
2013-01-30 |
Bioalliance Cv |
Antibodies recognizing a carbohydrate containing epitope on cd-43 and cea expressed on cancer cells and methods using same
|
US20090196918A1
(en)
*
|
2008-02-01 |
2009-08-06 |
University Of Kentucky Research Foundation |
Liposomal formulations of hydrophobic lactone drugs in the presence of metal ions
|
CA2718975A1
(en)
|
2008-04-10 |
2009-10-15 |
Cell Signaling Technology, Inc. |
Compositions and methods for detecting egfr mutations in cancer
|
WO2009150623A1
(en)
|
2008-06-13 |
2009-12-17 |
Pfizer Inc |
Treatment of chronic prostatitis
|
WO2010021750A2
(en)
|
2008-08-21 |
2010-02-25 |
The Johns Hopkins University |
Methods and compositions for administration of 3-halopyruvate and related compounds for the treatment of cancer
|
TWI516501B
(zh)
|
2008-09-12 |
2016-01-11 |
禮納特神經系統科學公司 |
Pcsk9拮抗劑類
|
PE20120169A1
(es)
*
|
2008-11-17 |
2012-02-29 |
Genentech Inc |
Metodo y formulacion para reducir la agregacion de una macromolecula bajo condiciones fisiologicas
|
WO2010086828A2
(en)
|
2009-02-02 |
2010-08-05 |
Rinat Neuroscience Corporation |
Agonist anti-trkb monoclonal antibodies
|
EP3549602A1
(en)
|
2009-03-06 |
2019-10-09 |
GlaxoSmithKline Biologicals S.A. |
Chlamydia antigens
|
NZ595212A
(en)
|
2009-03-30 |
2014-02-28 |
Eisai R&D Man Co Ltd |
Liposome composition
|
EP2415464B1
(en)
*
|
2009-03-30 |
2017-05-10 |
Eisai R&D Management Co., Ltd. |
Method for producing liposome composition
|
US20100297127A1
(en)
|
2009-04-08 |
2010-11-25 |
Ghilardi Nico P |
Use of il-27 antagonists to treat lupus
|
EP2510947B1
(en)
|
2009-04-14 |
2016-02-10 |
GlaxoSmithKline Biologicals SA |
Compositions for immunising against Staphylococcus aureus
|
ES2767880T3
(es)
|
2009-05-29 |
2020-06-18 |
Cydex Pharmaceuticals Inc |
Composiciones inyectables de melfalán que comprenden un derivado de ciclodextrina y métodos de preparación y uso de las mismas
|
US11020363B2
(en)
|
2009-05-29 |
2021-06-01 |
Cydex Pharmaceuticals, Inc. |
Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same
|
WO2010146511A1
(en)
|
2009-06-17 |
2010-12-23 |
Pfizer Limited |
Treatment of overactive bladder
|
PL2464658T3
(pl)
|
2009-07-16 |
2015-03-31 |
Novartis Ag |
Immunogeny z Escherichia coli o zniesionej toksyczności
|
GB0919690D0
(en)
|
2009-11-10 |
2009-12-23 |
Guy S And St Thomas S Nhs Foun |
compositions for immunising against staphylococcus aureus
|
US8298535B2
(en)
|
2010-02-24 |
2012-10-30 |
Rinat Neuroscience Corp. |
Anti-IL-7 receptor antibodies
|
GB201003333D0
(en)
|
2010-02-26 |
2010-04-14 |
Novartis Ag |
Immunogenic proteins and compositions
|
JP5932670B2
(ja)
|
2010-03-11 |
2016-06-08 |
ライナット ニューロサイエンス コーポレイション |
pH依存性の抗原結合を有する抗体
|
GB201005625D0
(en)
|
2010-04-01 |
2010-05-19 |
Novartis Ag |
Immunogenic proteins and compositions
|
WO2011133931A1
(en)
|
2010-04-22 |
2011-10-27 |
Genentech, Inc. |
Use of il-27 antagonists for treating inflammatory bowel disease
|
US9186642B2
(en)
|
2010-04-28 |
2015-11-17 |
The Procter & Gamble Company |
Delivery particle
|
US9993793B2
(en)
|
2010-04-28 |
2018-06-12 |
The Procter & Gamble Company |
Delivery particles
|
US9770414B2
(en)
*
|
2010-05-13 |
2017-09-26 |
Pacira Pharmaceuticals, Inc. |
Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (DMARD) and an anti-cancer agent
|
JP2013533286A
(ja)
|
2010-07-30 |
2013-08-22 |
セントルイス ユニバーシティ |
疼痛を治療する方法
|
JP6194248B2
(ja)
*
|
2010-10-28 |
2017-09-06 |
パシラ ファーマシューティカルズ インコーポレーテッド |
非ステロイド性抗炎症薬の徐放性処方物
|
WO2012072769A1
(en)
|
2010-12-01 |
2012-06-07 |
Novartis Ag |
Pneumococcal rrgb epitopes and clade combinations
|
WO2012118796A1
(en)
|
2011-02-28 |
2012-09-07 |
The Schepens Eye Research Institute, Inc. |
Compositions for controlling neuronal outgrowth
|
CN103458871B
(zh)
|
2011-04-07 |
2015-05-13 |
宝洁公司 |
具有增强的聚丙烯酸酯微胶囊的沉积的调理剂组合物
|
WO2012138710A2
(en)
|
2011-04-07 |
2012-10-11 |
The Procter & Gamble Company |
Personal cleansing compositions with increased deposition of polyacrylate microcapsules
|
JP5869663B2
(ja)
|
2011-04-07 |
2016-02-24 |
ザ プロクター アンド ギャンブルカンパニー |
ポリアクリレートマイクロカプセルの付着が増大したシャンプー組成物
|
US20130071375A1
(en)
|
2011-08-22 |
2013-03-21 |
Saint Louis University |
Compositions and methods for treating inflammation
|
WO2013028527A1
(en)
|
2011-08-23 |
2013-02-28 |
Indiana University Research And Technology Corporation |
Compositions and methods for treating cancer
|
CA2854720C
(en)
|
2011-11-11 |
2018-12-18 |
Rinat Neuroscience Corp. |
Antibodies specific for trop-2 and their uses
|
WO2013093693A1
(en)
|
2011-12-22 |
2013-06-27 |
Rinat Neuroscience Corp. |
Staphylococcus aureus specific antibodies and uses thereof
|
CA2859472A1
(en)
|
2011-12-22 |
2013-06-27 |
Rinat Neuroscience Corp. |
Human growth hormone receptor antagonist antibodies and methods of use thereof
|
RU2664700C2
(ru)
|
2012-05-10 |
2018-08-21 |
Пейнреформ Лтд. |
Депо-составы местного анестетика и способы их получения
|
ES2651113T3
(es)
|
2012-06-25 |
2018-01-24 |
The Brigham And Women's Hospital, Inc. |
Tratamientos terapéuticos dirigidos
|
AU2013286866B2
(en)
|
2012-07-02 |
2018-03-01 |
Commonwealth Scientific And Industrial Research Organization |
Paramyxovirus and methods of use
|
AU2013292636A1
(en)
*
|
2012-07-18 |
2015-02-05 |
Onyx Therapeutics, Inc. |
Liposomal compositions of epoxyketone-based proteasome inhibitors
|
US8603470B1
(en)
|
2012-08-07 |
2013-12-10 |
National Cheng Kung University |
Use of IL-20 antagonists for treating liver diseases
|
MX2015005874A
(es)
|
2012-11-09 |
2015-09-10 |
Pfizer |
Anticuerpos especificos del factor de crecimiento b derivados de plaquetas y composiciones y usos de estos.
|
BR112015022181A8
(pt)
|
2013-03-12 |
2018-01-23 |
Massachusetts Eye & Ear Infirmary |
proteínas da substância de inibição mulleriana (mis) e usos das mesmas para o tratamento de doenças
|
CN105051068A
(zh)
|
2013-03-15 |
2015-11-11 |
戴埃克斯有限公司 |
抗血浆激肽释放酶抗体
|
AU2014264295A1
(en)
|
2013-05-07 |
2015-10-29 |
Rinat Neuroscience Corp. |
Anti-glucagon receptor antibodies and methods of use thereof
|
TWM473835U
(zh)
*
|
2013-05-15 |
2014-03-11 |
Wu xu sheng |
微米牛樟芝微脂載體結構
|
US20170172922A1
(en)
*
|
2013-05-15 |
2017-06-22 |
Hsu-Shen WU |
Micron taiwanofungus camphoratus liposome structure
|
US10208125B2
(en)
|
2013-07-15 |
2019-02-19 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Anti-mucin 1 binding agents and uses thereof
|
MY190252A
(en)
|
2013-08-02 |
2022-04-08 |
Pfizer |
Anti-cxcr4 antibodies and antibody-drug conjugates
|
TWI736515B
(zh)
|
2013-11-13 |
2021-08-21 |
美商輝瑞大藥廠 |
類腫瘤壞死因子之配體1a之專一性抗體及其組合物及用途
|
WO2015087187A1
(en)
|
2013-12-10 |
2015-06-18 |
Rinat Neuroscience Corp. |
Anti-sclerostin antibodies
|
AU2014362307A1
(en)
|
2013-12-11 |
2016-06-30 |
The General Hospital Corporation |
Use of mullerian inhibiting substance (MIS) proteins for contraception and ovarian reserve preservation
|
US20180161274A1
(en)
*
|
2014-01-14 |
2018-06-14 |
The Johns Hopkins University |
Liposome Compositions Encapsulating Modified Cyclodextrin Complexes and Uses Thereof
|
WO2015109212A1
(en)
|
2014-01-17 |
2015-07-23 |
Pfizer Inc. |
Anti-il-2 antibodies and compositions and uses thereof
|
IL247853B
(en)
|
2014-03-21 |
2022-08-01 |
Teva Pharmaceuticals Int Gmbh |
Antibodies which are antagonists against a peptide relating to the calcitonin gene and methods of using them
|
US10308697B2
(en)
|
2014-04-30 |
2019-06-04 |
President And Fellows Of Harvard College |
Fusion proteins for treating cancer and related methods
|
US9840553B2
(en)
|
2014-06-28 |
2017-12-12 |
Kodiak Sciences Inc. |
Dual PDGF/VEGF antagonists
|
TWI595006B
(zh)
|
2014-12-09 |
2017-08-11 |
禮納特神經系統科學公司 |
抗pd-1抗體類和使用彼等之方法
|
US9758575B2
(en)
|
2015-04-06 |
2017-09-12 |
Yung Shin Pharmaceutical Industrial Co. Ltd. |
Antibodies which specifically bind to canine vascular endothelial growth factor and uses thereof
|
DK3283106T3
(da)
|
2015-04-13 |
2022-01-10 |
Pfizer |
Terapeutiske antistoffer og anvendelser deraf
|
TWM513697U
(zh)
*
|
2015-06-26 |
2015-12-11 |
Ma Shen Kai Ruei Co Ltd |
仿生物間質系統的載體結構
|
US10877045B2
(en)
|
2015-07-21 |
2020-12-29 |
Saint Louis University |
Compositions and methods for diagnosing and treating endometriosis-related infertility
|
NZ739088A
(en)
|
2015-07-21 |
2024-01-26 |
Takeda Pharmaceuticals Co |
A monoclonal antibody inhibitor of factor xiia
|
US11066481B2
(en)
|
2015-07-23 |
2021-07-20 |
The Regents Of The University Of California |
Antibodies to coagulation factor XIa and uses thereof
|
IL302353A
(en)
|
2015-08-19 |
2023-06-01 |
Pfizer |
TFPI inhibitory antibodies and their uses
|
EP3922645A1
(en)
|
2015-09-15 |
2021-12-15 |
Scholar Rock, Inc. |
Anti-pro/latent-myostatin antibodies and uses thereof
|
WO2017070561A1
(en)
|
2015-10-23 |
2017-04-27 |
Pfizer Inc. |
Anti-il-2 antibodies and compositions and uses thereof
|
WO2017075037A1
(en)
|
2015-10-27 |
2017-05-04 |
Scholar Rock, Inc. |
Primed growth factors and uses thereof
|
US10751306B2
(en)
|
2015-11-06 |
2020-08-25 |
The Johns Hopkins University |
Methods of treating liver fibrosis by administering 3-bromopyruvate
|
CN106699889A
(zh)
|
2015-11-18 |
2017-05-24 |
礼进生物医药科技(上海)有限公司 |
抗pd-1抗体及其治疗用途
|
WO2017117464A1
(en)
|
2015-12-30 |
2017-07-06 |
Kodiak Sciences Inc. |
Antibodies and conjugates thereof
|
AU2016380988B2
(en)
|
2015-12-30 |
2022-07-21 |
Genentech, Inc. |
Formulations with reduced degradation of polysorbate
|
CN109219618B
(zh)
|
2016-01-21 |
2022-08-09 |
辉瑞大药厂 |
针对表皮生长因子受体变体iii和cd3的单特异性和双特异性抗体及其用途
|
EP3541815A4
(en)
|
2016-11-18 |
2020-07-15 |
Pacira Pharmaceuticals, Inc. |
ZINC MELXICAM COMPLEX MICROPARTICLE MULTIVESICULAR LIPOSOME FORMULATIONS AND METHODS OF MAKING THE SAME
|
EP3589657A1
(en)
|
2017-03-03 |
2020-01-08 |
Rinat Neuroscience Corp. |
Anti-gitr antibodies and methods of use thereof
|
WO2018167621A1
(en)
|
2017-03-16 |
2018-09-20 |
Pfizer Inc. |
Tyrosine prototrophy
|
WO2018191548A2
(en)
|
2017-04-14 |
2018-10-18 |
Kodiak Sciences Inc. |
Complement factor d antagonist antibodies and conjugates thereof
|
KR20230035421A
(ko)
|
2017-06-02 |
2023-03-13 |
화이자 인코포레이티드 |
Flt3에 특이적인 항체 및 이의 용도
|
CA3066004A1
(en)
|
2017-06-13 |
2018-12-20 |
Bostongene Corporation |
Systems and methods for identifying cancer treatments from normalized biomarker scores
|
WO2019016784A1
(en)
|
2017-07-21 |
2019-01-24 |
Universidade De Coimbra |
ANTI-NUCLEOLIN ANTIBODIES
|
CN112020648A
(zh)
|
2017-10-04 |
2020-12-01 |
赫斯佩瑞克斯股份公司 |
针对癌症个体化疗法的制品和方法
|
WO2019094648A1
(en)
*
|
2017-11-08 |
2019-05-16 |
L.E.A.F. Holdings Group Llc |
Platinum complexes and uses thereof
|
TW201934580A
(zh)
|
2018-02-01 |
2019-09-01 |
美商輝瑞大藥廠 |
對cd70具特異性抗體及其用途
|
EP3746483A1
(en)
|
2018-02-01 |
2020-12-09 |
Pfizer Inc |
Chimeric antigen receptors targeting cd70
|
SG11202007518RA
(en)
|
2018-02-28 |
2020-09-29 |
Pfizer |
Il-15 variants and uses thereof
|
KR102602329B1
(ko)
|
2018-05-23 |
2023-11-16 |
화이자 인코포레이티드 |
Cd3에 특이적인 항체 및 이의 용도
|
WO2019224716A2
(en)
|
2018-05-23 |
2019-11-28 |
Pfizer Inc. |
Antibodies specific for gucy2c and uses thereof
|
EP3849560A4
(en)
*
|
2018-09-14 |
2022-06-08 |
Pharmosa Biopharm Inc. |
PHARMACEUTICAL COMPOSITION FOR THE CONTROLLED RELEASE OF WEAK ACID DRUGS AND THEIR USES
|
US11279774B2
(en)
|
2019-01-03 |
2022-03-22 |
Underdog Pharmaceuticals, Inc. |
Cyclodextrin dimers, compositions thereof, and uses thereof
|
AU2020327680A1
(en)
|
2019-07-03 |
2022-01-20 |
Bostongene Corporation |
Systems and methods for sample preparation, sample sequencing, and sequencing data bias correction and quality control
|
US11083705B2
(en)
|
2019-07-26 |
2021-08-10 |
Eisai R&D Management Co., Ltd. |
Pharmaceutical composition for treating tumor
|
AU2020363372A1
(en)
|
2019-10-07 |
2022-05-19 |
University Of Virginia Patent Foundation |
Modulating lymphatic vessels in neurological disease
|
AU2020364071A1
(en)
|
2019-10-10 |
2022-05-26 |
Kodiak Sciences Inc. |
Methods of treating an eye disorder
|
WO2021072244A1
(en)
|
2019-10-11 |
2021-04-15 |
Beth Israel Deaconess Medical Center, Inc. |
Anti-tn antibodies and uses thereof
|
US20230067811A1
(en)
|
2020-01-24 |
2023-03-02 |
University Of Virginia Patent Foundation |
Modulating lymphatic vessels in neurological disease
|
WO2021205325A1
(en)
|
2020-04-08 |
2021-10-14 |
Pfizer Inc. |
Anti-gucy2c antibodies and uses thereof
|
US20230181750A1
(en)
|
2020-05-06 |
2023-06-15 |
Crispr Therapeutics Ag |
Mask peptides and masked anti-ptk7 antibodies comprising such
|
CN116323668A
(zh)
|
2020-07-17 |
2023-06-23 |
辉瑞公司 |
治疗性抗体及其用途
|
CA3190227A1
(en)
|
2020-07-30 |
2022-02-03 |
Pfizer Inc. |
Cells having gene duplications and uses thereof
|
AU2021338361A1
(en)
|
2020-09-03 |
2023-04-06 |
Chen, Irvin S.Y |
Soluble alkaline phosphatase constructs and expression vectors including a polynucleotide encoding for soluble alkaline phosphatase constructs
|
CN112190498B
(zh)
*
|
2020-10-31 |
2022-03-25 |
华南理工大学 |
一种具有水溶性的茶碱和环糊精包合物及其制备方法
|
US20220180972A1
(en)
|
2020-12-04 |
2022-06-09 |
Bostongene Corporation |
Hierarchical machine learning techniques for identifying molecular categories from expression data
|
US11278494B1
(en)
|
2021-01-22 |
2022-03-22 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
US11033495B1
(en)
|
2021-01-22 |
2021-06-15 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
US11357727B1
(en)
|
2021-01-22 |
2022-06-14 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
EP4330969A1
(en)
|
2021-04-29 |
2024-03-06 |
BostonGene Corporation |
Machine learning techniques for estimating tumor cell expression in complex tumor tissue
|
WO2023012627A1
(en)
|
2021-08-02 |
2023-02-09 |
Pfizer Inc. |
Improved expression vectors and uses thereof
|
US20230245479A1
(en)
|
2022-01-31 |
2023-08-03 |
Bostongene Corporation |
Machine learning techniques for cytometry
|
WO2023148598A1
(en)
|
2022-02-02 |
2023-08-10 |
Pfizer Inc. |
Cysteine prototrophy
|
US20240029884A1
(en)
|
2022-07-15 |
2024-01-25 |
Bostongene Corporation |
Techniques for detecting homologous recombination deficiency (hrd)
|